Literature DB >> 31692081

Biofilm Producing Staphylococcus epidermidis (RP62A Strain) Inhibits Osseous Integration Without Osteolysis and Histopathology in a Murine Septic Implant Model.

Takuya Tomizawa1, Masahiro Ishikawa1,2, Sheila N Bello-Irizarry2, Karen L de Mesy Bentley2,3, Hiromu Ito1, Stephen L Kates4, John L Daiss2, Christopher Beck2,5, Shuichi Matsuda1, Edward M Schwarz2,5, Kohei Nishitani1,2.   

Abstract

Despite its presence in orthopaedic infections, Staphylococcus epidermidis's ability to directly induce inflammation and bone destruction is unknown. Thus, we compared a clinical strain of methicillin-resistant biofilm-producing S. epidermidis (RP62A) to a highly virulent and osteolytic strain of methicillin-resistant Staphylococcus aureus (USA300) in an established murine implant-associated osteomyelitis model. Bacterial burden was assessed by colony forming units (CFUs), tissue damage was assessed by histology and micro-computed tomography, biofilm was assessed by scanning electron microscopy (SEM), host gene expression was assessed by quantitative polymerase chain reaction, and osseous integration was assessed via biomechanical push-out test. While CFUs were recovered from RP62A-contaminated implants and surrounding tissues after 14 days, the bacterial burden was significantly less than USA300-infected tibiae (p < 0.001). In addition, RP62A failed to produce any of the gross pathologies induced by USA300 (osteolysis, reactive bone formation, Staphylococcus abscess communities, marrow necrosis, and biofilm). However, fibrous tissue was present at the implant-host interface, and rigorous SEM confirmed the rare presence of cocci on RP62A-contaminated implants. Gene expression studies revealed that IL-1β, IL-6, RANKL, and TLR-2 mRNA levels in RP62A-infected bone were increased versus Sterile controls. Ex vivo push-out testing showed that RP62A-infected implants required significantly less force compared with the Sterile group (7.5 ± 3.4 vs. 17.3 ± 4.1 N; p < 0.001), but required 10-fold greater force than USA300-infected implants (0.7 ± 0.3 N; p < 0.001). Taken together, these findings demonstrate that S. epidermidis is a commensal pathogen whose mechanisms to inhibit osseous integration are limited to minimal biofilm formation on the implant, and low-grade inflammation.
© 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 38:852-860, 2020. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  Staphylococcus epidermidis; biofilm; implant-associated osteomyelitis; loosening

Mesh:

Year:  2019        PMID: 31692081      PMCID: PMC7071979          DOI: 10.1002/jor.24512

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  42 in total

1.  Delayed short-course treatment with teriparatide (PTH(1-34)) improves femoral allograft healing by enhancing intramembranous bone formation at the graft-host junction.

Authors:  Masahiko Takahata; Edward M Schwarz; Tony Chen; Regis J O'Keefe; Hani A Awad
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

2.  Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections.

Authors:  Ekaterina V Kourbatova; Jesse S Halvosa; Mark D King; Susan M Ray; Nancy White; Henry M Blumberg
Journal:  Am J Infect Control       Date:  2005-09       Impact factor: 2.918

3.  Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control.

Authors:  M Nixon; B Jackson; P Varghese; D Jenkins; G Taylor
Journal:  J Bone Joint Surg Br       Date:  2006-06

4.  Profile of toll-like receptor-positive cells in septic and aseptic loosening of total hip arthroplasty implants.

Authors:  Jukka Pajarinen; Elisabetta Cenni; Lucia Savarino; Enrique Gomez-Barrena; Yasunobu Tamaki; Michiaki Takagi; Jari Salo; Yrjö T Konttinen
Journal:  J Biomed Mater Res A       Date:  2010-07       Impact factor: 4.396

Review 5.  2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions.

Authors:  Edward M Schwarz; Javad Parvizi; Thorsten Gehrke; Amiethab Aiyer; Andrew Battenberg; Scot A Brown; John J Callaghan; Mustafa Citak; Kenneth Egol; Grant E Garrigues; Michelle Ghert; Karan Goswami; Andrew Green; Sommer Hammound; Stephen L Kates; Alex C McLaren; Michael A Mont; Surena Namdari; William T Obremskey; Robert O'Toole; Steven Raikin; Camilo Restrepo; Benjamin Ricciardi; Kordo Saeed; Joaquin Sanchez-Sotelo; Noam Shohat; Timothy Tan; Caroline P Thirukumaran; Brian Winters
Journal:  J Orthop Res       Date:  2019-04-25       Impact factor: 3.494

6.  Obesity/type 2 diabetes increases inflammation, periosteal reactive bone formation, and osteolysis during Staphylococcus aureus implant-associated bone infection.

Authors:  Christopher W Farnsworth; Eric M Schott; Abigail M Benvie; Jacob Zukoski; Stephen L Kates; Edward M Schwarz; Steven R Gill; Michael J Zuscik; Robert A Mooney
Journal:  J Orthop Res       Date:  2018-01-03       Impact factor: 3.494

7.  Characterization of Staphylococcus epidermidis and Staphyloccocus warneri small-colony variants associated with prosthetic-joint infections.

Authors:  Agnieszka Bogut; Justyna Niedźwiadek; Maria Kozioł-Montewka; Dagmara Strzelec-Nowak; Jan Blacha; Tomasz Mazurkiewicz; Wojciech Marczyński; Dorota Plewik
Journal:  J Med Microbiol       Date:  2013-11-20       Impact factor: 2.472

8.  Staphylococcus aureus peptidoglycan promotes osteoclastogenesis via TLR2-mediated activation of the NF-κB/NFATc1 signaling pathway.

Authors:  Faqi Cao; Wu Zhou; Guohui Liu; Tian Xia; Mengfei Liu; Bobin Mi; Yi Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

9.  Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.

Authors:  O Goëau-Brissonnière; F Mercier; M H Nicolas; F Bacourt; M Coggia; C Lebrault; J C Pechère
Journal:  J Vasc Surg       Date:  1994-04       Impact factor: 4.268

10.  High percentage of microbial colonization of osteosynthesis material in clinically unremarkable patients.

Authors:  Ludwig Knabl; Bettina Kuppelwieser; Astrid Mayr; Wilfried Posch; Michaela Lackner; Débora Coraҫa-Huber; Adrian Danita; Michael Blauth; Cornelia Lass-Flörl; Dorothea Orth-Höller
Journal:  Microbiologyopen       Date:  2018-12-03       Impact factor: 3.139

View more
  2 in total

1.  Distinct vasculotropic versus osteotropic features of S. agalactiae versus S. aureus implant-associated bone infection in mice.

Authors:  Elysia A Masters; Stephanie P Hao; H Mark Kenney; Yugo Morita; Chad A Galloway; Karen L de Mesy Bentley; Benjamin F Ricciardi; Brendan F Boyce; Edward M Schwarz; Irvin Oh
Journal:  J Orthop Res       Date:  2020-12-29       Impact factor: 3.494

Review 2.  Skeletal infections: microbial pathogenesis, immunity and clinical management.

Authors:  Elysia A Masters; Benjamin F Ricciardi; Karen L de Mesy Bentley; T Fintan Moriarty; Edward M Schwarz; Gowrishankar Muthukrishnan
Journal:  Nat Rev Microbiol       Date:  2022-02-15       Impact factor: 78.297

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.